1. Germline Pharmacogenetics of Paclitaxel for Cancer Treatment
   Daniel L Hertz, 2013, Pharmacogenomics CrossRef
2. Genomic Architecture of Pharmacological Efficacy and Adverse Events
   Aparna Chhibber et al, 2014, Pharmacogenomics CrossRef
3. Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel
   Jean E. Abraham et al, 2014, Clinical Cancer Research CrossRef
4. Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)
   A Chhibber et al, 2014, The Pharmacogenomics Journal CrossRef
5. Informative gene network for chemotherapy-induced peripheral neuropathy
   Cielito C. Reyes-Gibby et al, 2015, BioData Mining CrossRef
6. Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
   Ganesh K. Boora et al, 2016, Cancer Medicine CrossRef
7. A SNP involved in alternative splicing of ABCB1 is associated with clopidogrel resistance in coronary heart disease in Chinese population
   Shasha Zhang et al, 2020, Aging CrossRef
8. GSTP1andABCB1Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel‐Based Chemotherapy in Ovarian Cancer
   Amanda Canato Ferracini et al, 2021, Clinical and Translational Science CrossRef
9. Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis
   Alberto Guijosa et al, 2022, Clinical and Translational Science CrossRef
10. The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis
    J. Cliff et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
11. Role of Cytochrome P450 2C8*3 ( CYP2C8*3 ) in Paclitaxel Metabolism and Paclitaxel-Induced Neurotoxicity
    Mi-Young Lee et al, 2015, Pharmacogenomics CrossRef